WESTBY KEITH (SVP & COO) sold 33.5% of their position (20K shares) of IVERIC BIO, INC. on the open market
Open‑market sale worth $757.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/6/2023ACC: 0001410939-23-000097
-20K
Net shares
Net seller
$757.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$2.94
Trade value
$58.80K
% of position
50.4%
6/2/2023
39.65K→59.65K
Common Stock
Direct
Shares
−20K
Price / share
$37.87
Trade value
$757.40K
% of position
33.5%
6/2/2023
59.65K→39.65K
Total
Net shares
+0.00
Net value
-$698.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2023 | M · Option Exercise | +20K | $2.94 | $58.80K | 50.4% | 39.65K | 59.65K |
| Common Stock Direct | 6/2/2023 | S · Sale | −20K | $37.87 | $757.40K | 33.5% | 59.65K | 39.65K |
| Total | +0.00 | -$698.60K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
2.94
Held after
100K
Exercisable
—
6/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock20K shares | 6/2/2023 | M · Option Exercise | −20K | 2.94 | — | 100K |